APT THERAPEUTICS, INC.

Company Information

Company Name
APT THERAPEUTICS, INC.
Address
4041 Forest Park Avenue
SAINT LOUIS, MO, 63108-3213
Phone
n/a
URL
n/a
DUNS
192266141
Number of Employees
n/a

Award Totals

PROGRAM/PHASE
AWARD AMOUNT ($)
NUMBER OF AWARDS
SBIR Phase I
$2,205,158.00
10
SBIR Phase II
$4,044,908.00
4
Chart code to be here

Award List

  1. Combination Treatment of tPA and Apyrase for Stroke

    Amount: $1,107,154.00

    DESCRIPTION (provided by applicant): Human apyrase represents a highly promising therapy for acute ischemic stroke which is a leading cause of death and disability with almost no effective therapy for ...

    SBIR Phase II 2010 Department of Health and Human Services
  2. Combination Therapy of Aspirin and Apyrase for Stroke

    Amount: $287,622.00

    DESCRIPTION (provided by applicant): Human apyrase represents a highly promising therapy for acute ischemic stroke which is a leading cause of death and disability with almost no effective therapy for ...

    SBIR Phase I 2010 Department of Health and Human Services
  3. Antithrombotic Effects of Optimized Human Apyrase

    Amount: $790,435.00

    DESCRIPTION (provided by applicant): The goal of the proposed work is to develop a novel antithrombotic drug that is safer and more effective than current therapies. Phase I funding for this project s ...

    SBIR Phase II 2006 Department of Health and Human Services
  4. Production of human CD39 as an antithrombotic agent

    Amount: $98,750.00

    DESCRIPTION (provided by applicant): Production of a human apyrase protein as an antithrombotic agent is proposed. Thrombotic vascular occlusion due to abnormal platelet aggregation can lead to many d ...

    SBIR Phase I 2004 Department of Health and Human Services
  5. Preclinical Validation of Human Apyrase in Stroke Models

    Amount: $187,435.00

    DESCRIPTION (provided by applicant): Human apyrase represents a highly promising therapy for acute ischemic stroke which is a leading cause of death and disability with almost no effective therapy for ...

    SBIR Phase I 2007 Department of Health and Human Services
  6. Apyrase to Treat Ischemia/Reperfusion Injury during Lung Transplantation

    Amount: $189,572.00

    DESCRIPTION (provided by applicant): Human apyrase represents a highly promising therapy to reduce ischemia/reperfusion injury which occurs in10-20% of lung transplant recipients as the consequence of ...

    SBIR Phase I 2007 Department of Health and Human Services
  7. Human Apyrase to Disrupt Cancer Therapy

    Amount: $196,745.00

    DESCRIPTION (provided by applicant): Human apyrase represents a highly promising therapy for inhibition of cancer metastasis. The enzyme strongly inhibits platelet activation and aggregation without i ...

    SBIR Phase I 2008 Department of Health and Human Services
  8. Adjunctive Use of Apyrase to Fibrinolytic Therapy

    Amount: $226,120.00

    DESCRIPTION (provided by applicant): Human apyrase represents a highly promising therapy for treatment of acute myocardial infarction. This enzyme strongly inhibits platelet activation and aggregation ...

    SBIR Phase I 2009 Department of Health and Human Services
  9. Apyrase to treat ischemia/reperfusion injury during lung transplantation

    Amount: $839,863.00

    DESCRIPTION (provided by applicant): Human apyrase represents a highly promising therapy to prevent or reduce ischemia-reperfusion injury during lung transplantation. The enzyme strongly preserves vas ...

    SBIR Phase II 2009 Department of Health and Human Services
  10. Adjunctive Use of Apyrase to Fibrinolytic Therapy

    Amount: $1,307,456.00

    DESCRIPTION (provided by applicant): Acute myocardial infarction is the leading cause of death in most industrialized nations. The estimated annual incidence in the US is 865,000 events, with ST-segm ...

    SBIR Phase II 2012 Department of Health and Human Services

Agency Micro-sites


SBA logo

Department of Agriculture logo

Department of Commerce logo

Department of Defense logo

Department of Education logo

Department of Energy logo

Department of Health and Human Services logo

Department of Homeland Security logo

Department of Transportation logo

Enviromental Protection Agency logo

National Aeronautics and Space Administration logo

National Science Foundation logo
US Flag An Official Website of the United States Government